Data / Drug companies / Vasopressin
Vasopressin: 15 companies and 30 products in the FDA NDC directory
Vasopressin is listed in the FDA National Drug Code Directory by 15 companies, with 30 products in commercial distribution. 15 of the products (50.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection; injection, solution; solution, and the newest product started marketing on October 22, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 30
- Generic (ANDA) products
- 15 (50.0%)
- Application numbers
- 9
- Routes
- Intravenous
- Brand names
- Vasostrict
- openFDA record search
- api.fda.gov
Companies that list vasopressin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | 5 | injection; injection, solution | New drug applications (NDA) | May 9, 2024 |
| Par Health USA, LLC | 5 | injection | New drug applications (NDA) | December 5, 2022 |
| Medical Purchasing Solutions, LLC | 4 | injection | New drug applications (NDA) | May 9, 2024 |
| American Regent, Inc. | 2 | injection, solution | New drug applications (NDA) | June 21, 2023 |
| Eugia US LLC | 2 | injection | Generic drugs (ANDA) | August 15, 2022 |
| Gland Pharma Limited | 2 | injection | Generic drugs (ANDA) | August 22, 2025 |
| Long Grove Pharmaceuticals, LLC | 2 | solution | New drug applications (NDA) | July 12, 2024 |
| Amneal Pharmaceuticals LLC | 1 | injection | Generic drugs (ANDA) | August 11, 2022 |
| Amphastar Pharmaceuticals, Inc. | 1 | injection | Generic drugs (ANDA) | August 22, 2022 |
| Civica, Inc. | 1 | injection, solution | New drug applications (NDA) | October 22, 2025 |
| Dr. Reddy's Laboratories Inc. | 1 | injection | Generic drugs (ANDA) | May 9, 2024 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | May 26, 2023 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | May 26, 2023 |
| ProPharma Distribution | 1 | injection | Generic drugs (ANDA) | August 15, 2022 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | November 15, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 20 | 66.7% |
| Injection, solution | 8 | 26.7% |
| Solution | 2 | 6.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 15 | 50% |
| Generic drugs (ANDA) | 15 | 50% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.